Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms (2022)
- Authors:
- USP affiliated authors: LOTUFO, LETICIA VERAS COSTA - ICB ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; VICARI, HUGO PASSOS - ICB ; LIMA, KELI CRISTINA DE - FM
- Unidades: ICB; FM
- DOI: 10.3390/cancers14246080
- Subjects: FARMACOLOGIA; LEUCEMIA; ANTINEOPLÁSICOS; MICROTÚBULOS; LEUCÓCITOS; GLICOPROTEÍNAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
VICARI, Hugo Passos et al. Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms. Cancers, v. 14, n. 24, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.3390/cancers14246080. Acesso em: 03 jun. 2024. -
APA
Vicari, H. P., Lima, K. C. de, Lotufo, L. V. C., & Machado Neto, J. A. (2022). Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms. Cancers, 14( 24), 1-15. doi:10.3390/cancers14246080 -
NLM
Vicari HP, Lima KC de, Lotufo LVC, Machado Neto JA. Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms [Internet]. Cancers. 2022 ; 14( 24): 1-15.[citado 2024 jun. 03 ] Available from: https://doi.org/10.3390/cancers14246080 -
Vancouver
Vicari HP, Lima KC de, Lotufo LVC, Machado Neto JA. Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms [Internet]. Cancers. 2022 ; 14( 24): 1-15.[citado 2024 jun. 03 ] Available from: https://doi.org/10.3390/cancers14246080 - Inibição farmacológica de ezrina reduz a viabilidade, a clonogenicidade e a ativação da via PI3K/AKT/mTOR em modelos celulares de leucemia mieloide aguda
- CDC7 (cell division cycle 7)
- Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms
- Synthetic cyclopenta[b]indoles exhibit antineoplastic activity by targeting microtubule dynamics in acute myeloid leukemia cells
- Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models
- miRNAs as prognostic predictors in acute myeloid leukemia [Editorial]
- Exploring redox vulnerabilities in JAK2V617F-positive cellular models
- Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax
- Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia
- BIRC5 (baculoviral IAP repeat containing 5)
Informações sobre o DOI: 10.3390/cancers14246080 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | Cellular and Molecular Ef... | Direct link | |
| Cellular and Molecular Ef... | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
